The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Xevudy (sotrovimab), a monoclonal antibody made by GlaxoSmithKline (GSK) and Vir Biotechnology, for people with mild to moderate Covid-19 at high risk of developing severe ...
from Google Alert - health https://ift.tt/3DcSMiJ
via IFTTT
0 comments:
Post a Comment